Thomas G. Frinzi is recorded as Board Member at Staar Surgical Co (STAA) since June 20, 2024 and CEO at Staar Surgical Co (STAA). The newest filing on record that lists Thomas G. Frinzi as CEO at Staar Surgical Co (STAA) is dated May 4, 2026. Staar Surgical Co reported in an 8-K filed December 19, 2022 that Thomas G. Frinzi was appointed CEO, effective January 1, 2023. The proxy statement of Staar Surgical Co reports total compensation of $1,255,915 for Thomas G. Frinzi in fiscal 2025, including a base salary of $167,154. Disclosed compensation is on record for 3 fiscal years. Thomas G. Frinzi has spoken on 1 earnings call across 1 company, most recently for Staar Surgical Co on May 7, 2024. Staar Surgical Co is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Staar Surgical Co includes Stephen C. Farrell (CEO), Stephen Farrell (CEO and Board Member), Thomas "Tom" G. Frinzi (CEO) and 7 others.
“On December 16, 2022, the Company announced that the Board elected Thomas G. Frinzi, currently Chair of the Board, to succeed Ms. Mason as CEO, effective January 1, 2023.”
Staar Surgical Co Form 8-K, filed December 19, 2022
· Read the filing
Thomas G. Frinzi on recent calls
“I'm pleased to report STAAR generated net sales of $77.4 million for the first quarter of 2024, which exceeded our outlook. Our enhanced commercial focus is yielding positive results.”
